+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor



Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor



Antiviral Chemistry and ChemoTherapy 20(1): 19-36



Hepatitis C virus (HCV) NS5B is an essential component of the viral replication machinery and an important target for antiviral intervention. Aurintricarboxylic acid (ATA), a broad-spectrum antiviral agent, was evaluated and characterized for its anti-NS5B activity in vitro and in HCV replicon cells. Recombinant NS5B, HCV replicase and Huh-7 cells harbouring the subgenomic HCV replicon of genotype 1b were employed for biochemical and mechanistic investigations. Analysis of ATA activity in vitro yielded equipotent inhibition of recombinant NS5B and HCV replicase in the submicromolar range (50% inhibition concentration [IC(50)] approximately 150 nM). Biochemical and mechanistic studies revealed a bimodal mechanism of ATA inhibition with characteristics of pyrophosphate mimics and non-nucleoside inhibitors. Molecular modelling and competition displacement studies were consistent with these parameters, suggesting that ATA might bind to the benzothiadiazine allosteric pocket 3 of NS5B or at its catalytic centre. Kinetic studies revealed a mixed mode of ATA inhibition with respect to both RNA and UTP substrates. Under single-cycle assay conditions, ATA inhibited HCV NS5B initiation and elongation from pre-bound RNA, but with > or =fivefold decreased potency compared with continuous polymerization conditions. The IC(50) value of ATA for the native replicase complex was 145 nM. In HCV replicon cells, ATA treatment ablated HCV RNA replication (50% effective concentration =75 nM) with concomitant decrease in NS5B expression and no apparent cytotoxic effects. This study identified ATA as a potent anti-NS5B inhibitor and suggests that its unique mode of action might be exploited for structural refinement and development of novel anti-NS5B agents.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052031091

Download citation: RISBibTeXText

PMID: 19794229

DOI: 10.3851/imp1286


Related references

Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. Plos one 4(12): E8350, 2009

Characterization and use of the potent ribonuclease inhibitor aurintricarboxylic acid for the isolation of RNA from animal tissues. Biochemical Journal 263(1): 73-80, 1989

Hepatitis C virus NS5A inhibitor daclatasvir allosterically impairs NS4B-involved protein-protein interactions within the viral replicase and disrupts the replicase quaternary structure in a replicase assembly surrogate system. Journal of General Virology 100(1): 69-83, 2019

A putative inhibitor of apoptosis, aurintricarboxylic acid is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 36: 445, 1995

Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells. Biochemical Pharmacology. 49(3): 305-313, 1995

Aurintricarboxylic acid is a potent inhibitor of phosphofructokinase. Biochemical Journal 259(3): 925-927, 1989

Characterization of V36C, a novel amino acid substitution conferring hepatitis C virus (HCV) resistance to telaprevir, a potent peptidomimetic inhibitor of HCV protease. Antimicrobial Agents and ChemoTherapy 54(6): 2681-2683, 2010

Aurintricarboxylic acid a potent inhibitor of glucose 6 phosphate dehydrogenase. Chemico Biological Interactions 17(1): 61-67, 1977

Mechanism of action of polymeric aurintricarboxylic acid, a potent inhibitor of protein--nucleic acid interactions. Biochemistry 19(18): 4299-4303, 1980

Fractionation and structural elucidation of the active components of aurintricarboxylic acid a potent inhibitor of protein nucleic acid interactions. Biochimica et Biophysica Acta 562(3): 534-546, 1979

Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid. Frontiers in Microbiology 10: 718, 2019

The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor. Chemical Communications 52(16): 3340-3343, 2016

Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor. Bioorganic and Medicinal Chemistry Letters 22(24): 7297-7301, 2012

Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Antimicrobial Agents and ChemoTherapy 53(6): 2544-2552, 2009

Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry 52(36): 6151-6159, 2013